Your browser doesn't support javascript.
loading
Evaluation of cAMS for 14C microtracer ADME studies: opportunities to change the current drug development paradigm.
Lozac'h, Frédéric; Fahrni, Simon; Maria, Daniele De; Welte, Caroline; Bourquin, Joël; Synal, Hans-Arno; Pearson, David; Walles, Markus; Camenisch, Gian.
Afiliação
  • Lozac'h F; Novartis Pharma AG, Novartis Institutes for Biomedical Research, PK Sciences, Fabrikstrasse 14, CH-4002 Basel, Switzerland.
  • Fahrni S; Ionplus AG, Dietikon, Switzerland.
  • Maria D; Eidgenössische Technische Hochschule Zürich, Department Physik, Zürich, Switzerland.
  • Welte C; Eidgenössische Technische Hochschule Zürich, Department Physik, Zürich, Switzerland.
  • Bourquin J; Ionplus AG, Dietikon, Switzerland.
  • Synal HA; Eidgenössische Technische Hochschule Zürich, Department Physik, Zürich, Switzerland.
  • Pearson D; Novartis Pharma AG, Novartis Institutes for Biomedical Research, PK Sciences, Fabrikstrasse 14, CH-4002 Basel, Switzerland.
  • Walles M; Novartis Pharma AG, Novartis Institutes for Biomedical Research, PK Sciences, Fabrikstrasse 14, CH-4002 Basel, Switzerland.
  • Camenisch G; Novartis Pharma AG, Novartis Institutes for Biomedical Research, PK Sciences, Fabrikstrasse 14, CH-4002 Basel, Switzerland.
Bioanalysis ; 10(5): 321-339, 2018 Mar 01.
Article em En | MEDLINE | ID: mdl-29451392
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridinas / Pirimidinas / Radioisótopos de Carbono Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piridinas / Pirimidinas / Radioisótopos de Carbono Idioma: En Ano de publicação: 2018 Tipo de documento: Article